📰 Simultaneous Treatment News
Simultaneous Treatment News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Simultaneous Treatment. Real-time updates on events, politics, business and more.
November 17, 2022
/PRNewswire/ -- Yesterday, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), celebrated the fourth annual – and most successful – BOTOX® Cosmetic Day yet....
November 2, 2022
/PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is inviting people across the country to take a "Moment for You" on Wednesday, November 16...
May 1, 2021
Peijia Medicals TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization News provided by Share this article Share this article SUZHOU, China, April 24, 2021 /PRNewswire/ -- A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne ® Transcatheter Aortic Valve Replacement System (hereinafter referred to as "TaurusOne ®") developed by Peijia Medical (Suzhou) Co., Ltd., located in Suzhou Ind...
April 26, 2021
26 aprile 2021 09:25 Fonte: Adnkronos #salute-e-benessere - SUZHOU, China, April 24, 2021 /PRNewswire/ -- A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne® Transcatheter Aortic Valve Replacement System (hereinafter referred to as "TaurusOne®") developed by Peijia Medical (Suzhou) Co., Ltd., located in Suzhou Industrial Park, Jiangsu Province, was officially approved for commercialization by the National Medical ...
April 25, 2021
Press release content from PR Newswire. The AP news staff was not involved in its creation. Peijia Medical’s TaurusOne® Transcatheter Aortic Valve Replacement System Approved for Commercialization April 25, 2021 GMT SUZHOU, China, April 24, 2021 /PRNewswire/ -- A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusOne®”) develope...
April 25, 2021
SUZHOU, China, April 24, 2021 /PRNewswire/ -- A new interventional solution from China for structural heart disease is about to be launched onto the market. Recently, TaurusOne Transcatheter